[1]
Z. Wu, “Nanoparticle drug delivery for reducing cytotoxicity and MDR risks to cancer patients”, J. Drug Delivery Ther., vol. 9, no. 3, pp. 502–504, May 2019, doi: 10.22270/jddt.v9i3.2626.